CD274 and neoplasm: The engineered EcN continuously converts ammonia accumulated in tumors into L-arginine, increases the number of tumor-infiltrating T cells, and exhibits marked synergistic effects with programmed cell death ligand 1 (PD-L1) blocking antibodies in tumor clearance [20].